Concepedia

Lauren G. Monovich

LG

16

Publications

958

Citations

16

H-Index

1999

Active since

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Gilead Sciences (United States)

University of Colorado Boulder

Lauren G. Monovich is an author at Novartis (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyBiochemistryDrug DiscoveryNatural SciencesMedicinal ChemistryChemical BiologyDrug DevelopmentPhysiologyCell Biology

Publications per year

1999–2023

16

Publications

16

Small-molecule WNK inhibition regulates cardiovascular and renal function

Ken Yamada, Hyi-Man Park, Dean F. Rigel et al. · Nature Chemical Biology · 2016 · 162 citations · Full text

Molecular Physiology, Kidney Research, Medicine +8

Total Synthesis of (+)-Isoschizandrin Utilizing a Samarium(II) Iodide-Promoted 8-Endo Ketyl−Olefin Cyclization

Gary A. Molander, Kelly M. George, Lauren G. Monovich · The Journal of Organic Chemistry · 2003 · 120 citations

Total Synthesis of (−)-Steganone Utilizing a Samarium(II) Iodide Promoted 8-Endo Ketyl−Olefin Cyclization

Lauren G. Monovich, Yvan Le Huérou, Magnus Rönn et al. · Journal of the American Chemical Society · 1999 · 101 citations

Chemical Engineering, 8-Endo Ketyl−olefin Cyclization, Engineering +15

Optimization of Halopemide for Phospholipase D2 inhibition

Lauren G. Monovich, Benjamin Mugrage, Elizabeth Quadros et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 99 citations · Full text

Medicinal Chemistry, Medicine, Mechanism Of Action +4

A novel kinase inhibitor establishes a predominant role for protein kinase D as a cardiac class IIa histone deacetylase kinase

Lauren G. Monovich, Richard B. Vega, Erik L. Meredith et al. · FEBS Letters · 2009 · 58 citations

Rows per page

1–5 of 16